Inflammatory Bowel Disease
IBD Precis® Ordering Logistics
Ordering IBD Precis is simple. The first step is to download the current test requisition and fill it out completely for your patient.
Scheduling a blood draw
- Follow the procedures your office has in place for referring patients to have their blood drawn for Prometheus testing.
- If you don’t have a process in place, advise your patient to call Prometheus Client Services at 888-423-5227, Monday through Friday, 6:00 am – 4:30 pm Pacific Time, to find a designated blood draw site in their area, if available.
- If there is not a draw site in the area, mobile phlebotomy may be available. Advise your patient to call 888-423-5227, option 5 to schedule a mobile draw, or an appointment can be scheduled online by clicking here. For questions about the scheduling process, please contact Prometheus Client Services for assistance.
- Important: Provide your patient with a fully completed test requisition and a copy of the front and back of their insurance card(s). Please remind them to give these items to the lab or mobile phlebotomist when their sample is collected.
Specimen Collection & Shipping Instructions
Please see the back of the test requisition for more information.
| Turnaround Time | 4 business days from date of receipt |
| Transport Requirements: | Ambient or refrigerated cold pack (do not freeze) |
| Specimen Type & Volume: | 2.0 mL serum (0.5 mL for peds) |
| Specimen Collection Tube: | Serum Separator Tube |
| Specimen Stability: | 7 days room temperature or 14 days refrigerated |
IBD Precis is part of the Prometheus continuum of care for IBD patients
IBD Precis is a laboratory-developed test that was developed, and analytically and clinically validated by Prometheus Laboratories Inc. under federal Clinical Laboratory Improvement Amendments (CLIA) guidelines, and is performed exclusively in our high complexity CLIA certified (05D0917432) and College of American Pathologists (CAP) accredited (6805501) clinical laboratory. As a laboratory developed test, it has not been cleared or approved by the US FDA. The test may be covered by one or more US pending or issued patents – see prometheuslabs.com/patents. Prometheus, IBD Precis, Anser, PredictrPK and Respondr are registered trademarks of Prometheus Laboratories Inc. All other trademarks or service marks are the property of their respective owners. This material is provided for general information purposes only, as an educational service for healthcare providers. It is not intended as a substitute for medical advice and/or consultation with a physician.